4,431
Views
192
CrossRef citations to date
0
Altmetric
Research Article

Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users

, PhD, , PhD, , BA & , PhD
Pages 23-30 | Received 05 Feb 2013, Accepted 28 Jun 2013, Published online: 08 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (30)

Katherine M. Wilds & Jordan R. Riddell. (2024) Cannabis Policy and Consumption: Taking into account Substitution Effects. Substance Use & Misuse 59:1, pages 97-109.
Read now
Maha N. Mian & Mitch Earleywine. (2023) Savoring as an intervention for cannabis use: acceptability, feasibility, and preliminary results. Addiction Research & Theory 31:4, pages 296-305.
Read now
Carolyn E. Pritchett, Heather Flynn, Yuxia Wang & James E. Polston. (2022) Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use. Substance Use & Misuse 57:13, pages 1883-1892.
Read now
Neta HaGani, Sharon Sznitman, Michael Dor, Gil Bar-Sela, Dana Oren, Lilia Margolis-Dorfman, Itay Goor-Aryeh & Manfred S Green. (2022) Attitudes Toward the Use of Medical Cannabis and the Perceived Efficacy, Side-effects and Risks: A Survey of Patients, Nurses and Physicians. Journal of Psychoactive Drugs 54:5, pages 393-402.
Read now
Jie Li, Yuan Zhang, Yu Zhou & Xue-song Feng. (2022) Cannabinoids: Recent Updates on Public Perception, Adverse Reactions, Pharmacokinetics, Pretreatment Methods and Their Analysis Methods. Critical Reviews in Analytical Chemistry 52:6, pages 1197-1222.
Read now
Jennifer Rup, Tom P. Freeman, Chris Perlman & David Hammond. (2022) Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status. Substance Use & Misuse 57:5, pages 719-729.
Read now
Whitney A. Brammer, Bridgid M. Conn, Ellen Iverson, Stephen E. Lankenau, Chaka Dodson & Carolyn F. Wong. (2022) Coping Motives Mediate the Association of Trauma History with Problematic Cannabis Use in Young Adult Medical Cannabis Patients and Non-Patient Cannabis Users. Substance Use & Misuse 57:5, pages 684-697.
Read now
Sarah A. Hartmann & Alison C. McLeish. (2022) Tolerance for specific negative affective states and coping-oriented cannabis use motives among college student cannabis users. Journal of American College Health 70:3, pages 911-917.
Read now
Brianna Costales, Sascha van Boemmel-Wegmann, Almut Winterstein & Richard Segal. (2021) Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in Florida. Journal of Psychoactive Drugs 53:3, pages 185-194.
Read now
Daniel J. Kruger, Jessica S. Kruger & R. Lorraine Collins. (2021) Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages. Drugs: Education, Prevention and Policy 28:1, pages 97-103.
Read now
Tess K. Drazdowski, Wendy L. Kliewer & Miesha Marzell. (2021) College students’ using marijuana to sleep relates to frequency, problematic use, and sleep problems. Journal of American College Health 69:1, pages 103-112.
Read now
James Alton Croker$suffix/text()$suffix/text(), Julie L. Bobitt, Kanika Arora & Brian Kaskie. (2021) Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois. Clinical Gerontologist 44:1, pages 66-79.
Read now
C. Hindocha, J. Cousijn, M. Rall & M. A. P. Bloomfield. (2020) The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review. Journal of Dual Diagnosis 16:1, pages 120-139.
Read now
Mallory J E Loflin, Kimberly Babson, James Sottile, Sonya B Norman, Staci Gruber & Marcel O Bonn-Miller. (2019) A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis. The American Journal of Drug and Alcohol Abuse 45:5, pages 506-513.
Read now
Daniel J. Kruger & Jessica S. Kruger. (2019) Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine. Journal of Psychoactive Drugs 51:1, pages 31-36.
Read now
Bridget Freisthler & Alexis Cooke. (2018) Do characteristics of marijuana use correspond to overall health levels for medical marijuana patients?. Journal of Substance Use 23:3, pages 307-311.
Read now
Gregory L. Sahlem, Rachel L. Tomko, Brian J. Sherman, Kevin M. Gray & Aimee L. McRae-Clark. (2018) Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. International Review of Psychiatry 30:3, pages 216-225.
Read now
Jacob T. Borodovsky & Alan J. Budney. (2018) Cannabis regulatory science: risk–benefit considerations for mental disorders. International Review of Psychiatry 30:3, pages 183-202.
Read now
Carola Rong, Nicole E. Carmona, Yena L. Lee, Renee-Marie Ragguett, Zihang Pan, Joshua D. Rosenblat, Mehala Subramaniapillai, Margarita Shekotikhina, Fahad Almatham, Asem Alageel, Rodrigo Mansur, Roger C. Ho & Roger S. McIntyre. (2018) Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents. Expert Opinion on Drug Safety 17:1, pages 51-54.
Read now
Danilo A. Nader & Zila M. Sanchez. (2018) Effects of regular cannabis use on neurocognition, brain structure, and function: a systematic review of findings in adults. The American Journal of Drug and Alcohol Abuse 44:1, pages 4-18.
Read now
Gordon D Ko, Sara L Bober, Sean Mindra & Jason M Moreau. (2016) Medical cannabis – the Canadian perspective. Journal of Pain Research 9, pages 735-744.
Read now
Benjamin Kelmendi, Thomas G. Adams, Stephanie Yarnell, Steven Southwick, Chadi G. Abdallah & John H. Krystal. (2016) PTSD: from neurobiology to pharmacological treatments. European Journal of Psychotraumatology 7:1.
Read now
Deirdre A. Conroy, Megan E. Kurth, David R. Strong, Kirk J. Brower & Michael D. Stein. (2016) Marijuana use patterns and sleep among community-based young adults. Journal of Addictive Diseases 35:2, pages 135-143.
Read now
William D. Troutt & Matthew D. DiDonato. (2015) Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization. Journal of Psychoactive Drugs 47:4, pages 259-266.
Read now
Marcel O. Bonn-Miller, Rudolf H. Moos, Matthew Tyler Boden, W. Robert Long, Rachel Kimerling & Jodie A. Trafton. (2015) The impact of posttraumatic stress disorder on cannabis quit success. The American Journal of Drug and Alcohol Abuse 41:4, pages 339-344.
Read now
Nicole A. Short, Kimberly A. Babson, Matthew Tyler Boden & Marcel O. Bonn-Miller. (2015) Sleep quality, problematic cannabis use and posttraumatic stress symptoms among medical cannabis users. Addiction Research & Theory 23:3, pages 246-252.
Read now
Nickolas Zaller, Ariel Topletz, Susan Frater, Gail Yates & Michelle Lally. (2015) Profiles of Medicinal Cannabis Patients Attending Compassion Centers in Rhode Island. Journal of Psychoactive Drugs 47:1, pages 18-23.
Read now
Christine E. Grella, Luz Rodriguez & Tina Kim. (2014) Patterns of Medical Marijuana Use Among Individuals Sampled from Medical Marijuana Dispensaries in Los Angeles. Journal of Psychoactive Drugs 46:4, pages 263-272.
Read now
Ryan Vandrey, Kimberly A. Babson, Evan S. Herrmann & Marcel O. Bonn-Miller. (2014) Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders. International Review of Psychiatry 26:2, pages 237-247.
Read now

Articles from other publishers (162)

Sabrina Giguère, Laura Dellazizzo, Mélissa Beaudoin, Marie-Andrée Lapierre, Marie Villeneuve, Kingsada Phraxayavong, Stéphane Potvin & Alexandre Dumais. (2023) Avatar Intervention for Cannabis Use Disorder in a Patient with Schizoaffective Disorder: A Case Report. BioMedInformatics 3:4, pages 1112-1123.
Crossref
Antonio ViganoYola MorideYasmina Hachem, Michelle Canac-MarquisRihab GamaounMaja Kalaba, Marc O. MartelJordi PerezAndrée NéronPierre BeaulieuJulie DesrochesMark Ware. (2023) The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis. Cannabis and Cannabinoid Research 8:6, pages 1106-1116.
Crossref
Wesley Oosten, Elena Vos, Leontien Los, Michel Nelwan & Toine Pieters. (2023) Towards a New Dynamic Interaction Model of Adolescent CUD Manifestation, Prevention, and Treatment: A Narrative Review. Psychoactives 2:4, pages 294-316.
Crossref
Shahida Anusha Siddiqui, Hafize Fidan, Stanko Stankov, Mohammad Mehdizadeh, Tigran Garrievich Ambartsumov, Mohammad Kharazmi, Shubhra Singh & Seid Mahdi Jafari. (2023) Are cannabidiol (CBD) levels in consumer food products well tested?—A review. Food Frontiers.
Crossref
Lisa R. Miller-Matero, Kaitlin Ross, Camila Arellano, Logan Zelenak, Eve DePascale, Lyubov Gavrilova, Jordan M. Braciszewski, Leah M. Hecht, Erin N. Haley, Carly Brescacin & Arthur M. Carlin. (2023) Cannabis use following bariatric surgery is associated with anxiety and maladaptive eating. Surgery for Obesity and Related Diseases.
Crossref
Elise Lorenzo, Carina McClean & Jason A. Ford. (2023) Young Adult Medical Cannabis Patients in Florida: Gender Differences in Characteristics of use, Experiences at Dispensaries, and Association With Health-Related Problems. Journal of Drug Issues.
Crossref
Katherine J. Hoggatt, Neetu Chawla, Donna L. Washington & Elizabeth M. Yano. (2023) Trends in substance use disorder diagnoses among Veterans, 2009–2019. The American Journal on Addictions 32:4, pages 393-401.
Crossref
Romina Sotoodeh, Lilach Eyal Waldman, Antonio Vigano, Yola Moride, Michelle Canac‐Marquis, Tristan Spilak, Rihab Gamaoun, Maja Kalaba, Yasmina Hachem, Pierre Beaulieu, Julie Desroches, Mark A. Ware, Jordi Perez, Yoram Shir, Mary‐Ann Fitzcharles & Marc O. Martel. (2023) Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long‐Term Prospective Cohort Study . Arthritis Care & Research 75:7, pages 1588-1594.
Crossref
Eric Fordjour, Charles F. Manful, Albert A. Sey, Rabia Javed, Thu Huong Pham, Raymond Thomas & Mumtaz Cheema. (2023) Cannabis: a multifaceted plant with endless potentials. Frontiers in Pharmacology 14.
Crossref
Alan D. BellCaroline MacCallum, Shari MargoleseZach WalshPatrick WrightPaul J. DaeninckEnrico MandarinoGary Lacasse, Jagpaul Kaur DeolLauren de FreitasMichelle St. Pierre, Lynne Belle-IsleMarilou GagnonSian BevanTatiana SanchezStephanie ArltMax Monahan-EllisonJames O'HaraMichael BoivinCecilia Costiniuk, Nancy Chow, Rob Sealey & Lynda Balneaves. (2023) Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. Cannabis and Cannabinoid Research.
Crossref
Ruibin Lu. (2023) Marijuana Policies in Drug Treatment Courts. Journal of Drug Issues, pages 002204262311637.
Crossref
Stephanie LakeRyan D. AssafPamina M. GorbachZiva D. Cooper. (2023) Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States. Cannabis and Cannabinoid Research 8:1, pages 174-183.
Crossref
Paige E. Morris & Julia D. Buckner. (2023) Cannabis-related problems and social anxiety: The roles of sex and cannabis use motives updated. Addictive Behaviors 137, pages 107528.
Crossref
Toni C. Spinella, Jeremy Bartholomeusz, Sherry H. Stewart & Sean P. Barrett. (2023) Perceptions about THC and CBD effects among adults with and without prior cannabis experience. Addictive Behaviors 137, pages 107508.
Crossref
Margaret Besse, Kajal Parikh & Katrina Mark. (2023) Reported Reasons for Cannabis Use Before and After Pregnancy Recognition. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Elizabeth A. Lehinger, Scott Graupensperger, Frank Song, Brittney A. Hultgren, Dara Jackson & Mary E. Larimer. (2023) Posttraumatic stress symptoms and substance use among college students: Exploring interactions with sleep quality and assigned sex. Addictive Behaviors 136, pages 107482.
Crossref
Anthony N. Reffi, Bhanu Prakash Kolla, Mandilyn Graham, M. Elizabeth Cardoni, Sajni Amin, Deirdre A. Conroy & J. Todd Arnedt. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms 413 427 .
Kimberly A. Bell, Elijah Coleman, Benson G. Cooke & Larry D. Keen. (2022) Recreational cannabis use is associated with poorer sleep outcomes in young adult African Americans. Addictive Behaviors 134, pages 107399.
Crossref
Ethan B. Russo, Carrie Cuttler, Ziva D. Cooper, Amanda StueberVenetia L. WhiteleyMichelle Sexton. (2022) Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis and Cannabinoid Research 7:5, pages 706-716.
Crossref
Laura MacNair, Maja Kalaba, Erica N. Peters, Matthew T. Feldner, Graham M. L. Eglit, Lucile Rapin, Cynthia El Hage, Erin Prosk & Mark A. Ware. (2022) Medical cannabis authorization patterns, safety, and associated effects in older adults. Journal of Cannabis Research 4:1.
Crossref
Pia M. Mauro, Morgan M. Philbin, Emily R. Greene, José E. Diaz, Melanie S. Askari & Silvia S. Martins. (2022) Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context. Preventive Medicine Reports 28, pages 101822.
Crossref
Rebecca L. Ashare, Erin Kelly, Emily R. Hajjar, Swechhya Pant, Salimah H. Meghani & Brooke Worster. (2022) Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program. Complementary Therapies in Clinical Practice 48, pages 101612.
Crossref
Llewellyn Mills, Nicholas Lintzeris, Michael O'Malley, Jonathon C. Arnold & Iain S. McGregor. (2022) Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. Drug and Alcohol Review 41:5, pages 1095-1108.
Crossref
Faraz Sachedina, Carole Chan, Rahim S. Damji & Olga J. de Sanctis. (2022) Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study. Psychiatry Research 313, pages 114573.
Crossref
Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, April Christiansen, Michael Boivin & Melissa Snider-Adler. (2022) A Clinical Framework for Assessing Cannabis-Related Impairment Risk. Frontiers in Psychiatry 13.
Crossref
Michele Bedard-Gilligan, Elizabeth Lehinger, Sarah Cornell-Maier, Ash Holloway & Lori Zoellner. (2022) Effects of Cannabis on PTSD Recovery: Review of the Literature and Clinical Insights. Current Addiction Reports 9:3, pages 203-216.
Crossref
Nicole A. Short, Mariah K. Evans, Alexa M. Raudales, Mary Shapiro, Nicole H. Weiss & Norman B. Schmidt. (2022) Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users. The American Journal on Addictions 31:3, pages 242-250.
Crossref
Lauren Kuhns, Emese Kroon, Karis Colyer-Patel & Janna Cousijn. (2021) Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. Psychopharmacology 239:5, pages 1231-1249.
Crossref
Arthur Robin Williams, Christine M. MauroTianshu FengJosef WaplesSilvia S. MartinsMargaret Haney. (2022) Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use. Cannabis and Cannabinoid Research.
Crossref
Amanda Stueber & Carrie Cuttler. (2021) Self-Reported Effects of Cannabis on ADHD Symptoms, ADHD Medication Side Effects, and ADHD-Related Executive Dysfunction. Journal of Attention Disorders 26:6, pages 942-955.
Crossref
Galen Missig, Niyati Mehta, James O. Robbins, Cameron H. Good, Christos Iliopoulos-Tsoutsouvas, Alex Makriyannis, Spyros P. Nikas, Jack Bergman, William A. Carlezon & Carol A. Paronis. (2022) Altered sleep during spontaneous cannabinoid withdrawal in male mice. Behavioural Pharmacology 33:2&3, pages 195-205.
Crossref
Calvin Diep, Chenchen Tian, Kathak Vachhani, Christine Won, Duminda N Wijeysundera, Hance Clarke, Mandeep Singh & Karim S Ladha. (2022) Recent cannabis use and nightly sleep duration in adults: a population analysis of the NHANES from 2005 to 2018. Regional Anesthesia & Pain Medicine 47:2, pages 100-104.
Crossref
Pablo Romero-Sanchiz, Ioan T. Mahu, Sean P. Barrett, Joshua P. Salmon, Mohammed Al-Hamdani, Jennifer E. Swansburg & Sherry H. Stewart. (2022) Craving and emotional responses to trauma and cannabis cues in trauma-exposed cannabis users: Influence of PTSD symptom severity. Addictive Behaviors 125, pages 107126.
Crossref
Margaret Haney. (2022) Cannabis Use and the Endocannabinoid System: A Clinical Perspective. American Journal of Psychiatry 179:1, pages 21-25.
Crossref
Jessica Rice, Andrea Hildebrand, Carin S. Waslo, Michelle H. Cameron & Kim Dupree Jones. (2022) Cannabis for medical purposes: A cross-sectional analysis of health care professionals' knowledge. Journal of the American Association of Nurse Practitioners 34:1, pages 100-106.
Crossref
Rishi Banerjee, Simon Erridge, Oliver Salazar, Nagina Mangal, Daniel Couch, Barbara Pacchetti & Mikael Hans Sodergren. (2021) Real World Evidence in Medical Cannabis Research. Therapeutic Innovation & Regulatory Science 56:1, pages 8-14.
Crossref
Anna McDowell. 2022. Cannabis in Psychiatric Practice. Cannabis in Psychiatric Practice 1 10 .
Stefan Kloiber, Justin Matheson, Helena K. Kim & Bernard Le Foll. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1005 1038 .
Jonathan Ross, Deepika E Slawek, Chenshu Zhang, Joanna L Starrels, Frances R Levin, Nancy L Sohler, Haruka Minami, Julia H Arnsten & Chinazo O Cunningham. (2021) First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort Study. Pain Medicine 22:12, pages 3080-3088.
Crossref
Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Mark Ware, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye & Clermont E. Dionne. (2021) Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. Journal of Cannabis Research 3:1.
Crossref
Lucile Rapin, Rihab Gamaoun, Cynthia El Hage, Maria Fernanda Arboleda & Erin Prosk. (2021) Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic. Journal of Cannabis Research 3:1.
Crossref
Ava Mason, Musa Sami, Caitlin Notley & Sagnik Bhattacharyya. (2021) Are researchers getting the terms used to denote different types of recreational cannabis right?—a user perspective. Journal of Cannabis Research 3:1.
Crossref
Nicolas J. SchlienzRyan ScalskyErin L. MartinHeather JacksonJoel MunsonJustin C. StricklandMarcel O. Bonn-MillerMallory LoflinRyan Vandrey. (2021) A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health. Cannabis and Cannabinoid Research 6:6, pages 548-558.
Crossref
Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark & Mark S Wallace. (2021) The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. JNCI Monographs 2021:58, pages 86-98.
Crossref
Elizabeth K. Do, Albert J. Ksinan, Sunny Jung Kim, Egidio G. Del Fabbro & Bernard F. Fuemmeler. (2021) Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample. Cancer 127:21, pages 4040-4049.
Crossref
Wendy M Troxel, Anthony Rodriguez, Rachana Seelam, Joan S Tucker, Regina A Shih, Lu Dong & Elizabeth J D’Amico. (2021) Longitudinal associations of sleep problems with alcohol and cannabis use from adolescence to emerging adulthood. Sleep 44:10.
Crossref
Aksinya Bilaonova, Joy Phillips & Kristen Anderson. (2021) Comparison of CBD and Cannabis Use Motives. Cannabis 4:2, pages 60-68.
Crossref
Nicholas C. Glodosky, Carrie Cuttler & Ryan J. McLaughlin. (2021) A review of the effects of acute and chronic cannabinoid exposure on the stress response. Frontiers in Neuroendocrinology 63, pages 100945.
Crossref
Erin L. Martin, Justin C. Strickland, Nicolas J. Schlienz, Joel Munson, Heather Jackson, Marcel O. Bonn-Miller & Ryan Vandrey. (2021) Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial. Frontiers in Psychiatry 12.
Crossref
Lyndsey L. Anderson, Peter T. Doohan, Lachlan Oldfield, Richard C. Kevin, Jonathon C. Arnold, Maximus Berger, G. Paul Amminger & Iain S. McGregor. (2021) Citalopram and Cannabidiol. Journal of Clinical Psychopharmacology 41:5, pages 525-533.
Crossref
Salar Vaseghi, Shirin Arjmandi-Rad, Mohammad Nasehi & Mohammad-Reza Zarrindast. (2021) Cannabinoids and sleep-wake cycle: The potential role of serotonin. Behavioural Brain Research 412, pages 113440.
Crossref
Danielle C. HergertCidney Robertson-BentaVeronik SicardDaniela SchwotzerKent HutchisonDan P. CoveyDavin K. QuinnJoseph R. SadekJacob McDonaldAndrew R. Mayer. (2021) Use of Medical Cannabis to Treat Traumatic Brain Injury. Journal of Neurotrauma 38:14, pages 1904-1917.
Crossref
Anne K Schlag, Chandni Hindocha, Rayyan Zafar, David J Nutt & H Valerie Curran. (2021) Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of Psychopharmacology 35:7, pages 773-785.
Crossref
Caroline A. MacCallum, Lindsay A. Lo & Michael Boivin. (2021) “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine 89, pages 10-18.
Crossref
Andrew J. Kesner & David M. Lovinger. (2021) Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings. Journal of Neurochemistry 157:5, pages 1674-1696.
Crossref
Daniel J. Kruger, Jessica S. Kruger, Edward M. Bednarczyk & William Allan PrescottJrJr. (2021) Cannabis education in United States Pharmacy Colleges and Schools. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 4:5, pages 616-621.
Crossref
Luca SteardoJr.Jr., Elvira Anna Carbone, Giulia Menculini, Patrizia Moretti, Luca Steardo & Alfonso Tortorella. (2021) Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review. Life 11:3, pages 214.
Crossref
Iva Skobic, Gabriella R. Apolinar, Stuart F. Quan & Patricia L. Haynes. (2021) Marijuana versus evidence-based treatments for sleep and relaxation: A cross-sectional study of use and dose modification following involuntary job loss. Sleep Health 7:1, pages 113-117.
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberArthur Williams. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
Stefan Kloiber, Justin Matheson, Helena K. Kim & Bernard Le Foll. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 35 .
Kylie O'Brien & Philip BlairKylie O’Brien & Philip Blair. 2021. Medicinal Cannabis and CBD in Mental Healthcare. Medicinal Cannabis and CBD in Mental Healthcare 253 320 .
Christina Le-Short & Samer N. Narouze. 2021. Cannabinoids and Pain. Cannabinoids and Pain 15 17 .
Kevin L. Sun, Vinita Shivakumar & Anita R. Kishore. 2021. Transition-Age Youth Mental Health Care. Transition-Age Youth Mental Health Care 123 151 .
Jonathan Ek, William Jacobs, Brett Kaylor & W. Vaughn McCall. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep 163 171 .
V. Kishan Mahabir, Jamil J. Merchant, Christopher Smith & Alisha Garibaldi. (2020) Medical cannabis use in the United States: a retrospective database study. Journal of Cannabis Research 2:1.
Crossref
Nicholas Lintzeris, Llewellyn Mills, Anastasia Suraev, Maria Bravo, Thomas Arkell, Jonathon C. Arnold, Melissa J. Benson & Iain S. McGregor. (2020) Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18). Harm Reduction Journal 17:1.
Crossref
Ana Maria Raymundi, Thiago R. da Silva, Jeferson M. B. Sohn, Leandro J. Bertoglio & Cristina A. Stern. (2020) Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies. BMC Psychiatry 20:1.
Crossref
Devan Kansagara, Benjamin J Morasco, Megan O Iacocca, Matthew J Bair, Elizabeth R Hooker & William C Becker. (2020) Clinician Knowledge, Attitudes, and Practice Regarding Cannabis: Results from a National Veterans Health Administration Survey. Pain Medicine 21:11, pages 3180-3186.
Crossref
Danielle C. Hergert, Andrew R. Mayer, Kent Hutchinson, Joseph R. Sadek & Davin K. Quinn. (2020) Medical Cannabis Reduced Agitation in Acquired Brain Injury: A Case Study. Psychosomatics 61:6, pages 819-824.
Crossref
Jasmine Turna, Iris Balodis, Catharine Munn, Michael Van Ameringen, Jason Busse & James MacKillop. (2020) Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users. Comprehensive Psychiatry 102, pages 152188.
Crossref
Yael Dagan & Joel Yager. (2020) Cannabis and Complex Posttraumatic Stress Disorder. Journal of Nervous & Mental Disease 208:8, pages 619-627.
Crossref
Daniel Feingold, Silviu Brill, Itay Goor-Aryeh, Yael Delayahu & Shaul Lev-Ran. (2020) Depression level, not pain severity, is associated with smoked medical marijuana dosage among chronic pain patients. Journal of Psychosomatic Research 135, pages 110130.
Crossref
Andrew J. Kesner & David M. Lovinger. (2020) Cannabinoids, Endocannabinoids and Sleep. Frontiers in Molecular Neuroscience 13.
Crossref
H. Raymond Allen, Doug Boudreaux & Jeffrey N. Keller. (2020) Comparison of Male and Female Patients in Louisiana Medical Marijuana Dispensaries. Journal of Clinical Medicine 9:6, pages 1865.
Crossref
Daniel J. Kruger, Jessica S. Kruger & R. Lorraine Collins. (2020) Cannabis Enthusiasts’ Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use. American Journal of Health Promotion 34:4, pages 436-439.
Crossref
Navin Kumar, Cheneal Puljević & Robert Heimer. (2020) Understanding motivations for large US cannabis firms' participation in the cannabis space: Qualitative study exploring views of key decision‐makers. Drug and Alcohol Review 39:4, pages 347-355.
Crossref
Kenneth B Chapman, Martijn M Pas, Diana Abrar, Wesley Day, Kris C Vissers & Noud van Helmond. (2020) Development and Performance of a Web-Based Tool to Adjust Urine Toxicology Testing Frequency: Retrospective Study. JMIR Medical Informatics 8:4, pages e16069.
Crossref
Aaron Glickman & Dominic Sisti. (2020) Prescribing medical cannabis: ethical considerations for primary care providers. Journal of Medical Ethics 46:4, pages 227-230.
Crossref
Melissa J Benson, Sarah V Abelev, Susan J Connor, Crispin J Corte, Lewis J Martin, Lucy K Gold, Anastasia S Suraev & Iain S McGregor. (2020) Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients. Crohn's & Colitis 360 2:2.
Crossref
Anees Bahji, Callum Stephenson, Richard Tyo, Emily R. Hawken & Dallas P. Seitz. (2020) Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids. JAMA Network Open 3:4, pages e202370.
Crossref
Janet Douglas, D. Margo Nelson, Paul Sunga & Daryl Smith. (2020) Cannabis Use and Baby Boomers: Attitudes and Patterns of Consumption. Cannabis 3:1, pages 1-10.
Crossref
Devan Kansagara, William C. Becker, Chelsea Ayers & Jeanette M. Tetrault. (2019) Priming primary care providers to engage in evidence-based discussions about cannabis with patients. Addiction Science & Clinical Practice 14:1.
Crossref
Nicola Black, Emily Stockings, Gabrielle Campbell, Lucy T Tran, Dino Zagic, Wayne D Hall, Michael Farrell & Louisa Degenhardt. (2019) Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. The Lancet Psychiatry 6:12, pages 995-1010.
Crossref
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, Suzanne Sisley, Daniel J. Clauw, Jenna Goesling & David A. Williams. (2019) Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain. The Journal of Pain 20:11, pages 1362-1372.
Crossref
Melissa Yuan, Theodora Kanellopoulos & Nabil Kotbi. (2019) Cannabis use and psychiatric illness in the context of medical marijuana legalization: A clinical perspective. General Hospital Psychiatry 61, pages 82-83.
Crossref
Elena Bilevicius, Jordana L. Sommer, Gordon J. G. Asmundson & Renée El‐Gabalawy. (2019) Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study. Depression and Anxiety 36:11, pages 1036-1046.
Crossref
I. G. Silkis. (2019) The Possible Mechanism of the Appearance of Nightmares in Post-Traumatic Stress Disorder and Approaches to Their Prevention. Neurochemical Journal 13:4, pages 320-334.
Crossref
Wajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, Silvia Alessi‐Severini, James M. Bolton, Paul Daeninck & Christine Leong. (2019) Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population‐based cohort study. Addiction 114:10, pages 1791-1799.
Crossref
Laura Orsolini, Stefania Chiappini, Umberto Volpe, Domenico De Berardis, Roberto Latini, Gabriele Papanti & John Corkery. (2019) Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina 55:9, pages 525.
Crossref
Anuj Shah, Corey J. Hayes, Mrinmayee Lakkad & Bradley C. Martin. (2019) Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. Journal of General Internal Medicine 34:8, pages 1419-1426.
Crossref
Michael Stillman, Maclain Capron, Michael Mallow, Tracy Ransom, Kristin Gustafson, Alison Bell & Daniel Graves. (2019) Utilization of medicinal cannabis for pain by individuals with spinal cord injury. Spinal Cord Series and Cases 5:1.
Crossref
Jonathon Lisano, Kristina Phillips, Jeremy Smith, Matthew Barnes & Laura Stewart. (2019) Patterns and Perceptions of Cannabis Use with Physical Activity. Cannabis 2:2, pages 151-164.
Crossref
Tara Marie Watson, Robert E. Mann, Christine M. Wickens & Bruna Brands. (2019) “Just a Habit”: Driving Under the Influence of Cannabis as Ordinary, Convenient, and Controllable Experiences According to Drivers in a Remedial Program. Journal of Drug Issues 49:3, pages 531-544.
Crossref
Jesse D. Kosiba, Stephen A. Maisto & Joseph W. Ditre. (2019) Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine 233, pages 181-192.
Crossref
Laura Daly, Caroline E. Gibson & Jan Dewing. (2019) Caring for people with multiple sclerosis who use cannabis for symptom control. British Journal of Community Nursing 24:6, pages 257-257.
Crossref
Kerry M. Green & Amelia M. Arria. (2019) Commentary on Terry‐McElrath et al . (2019): Will persistent patterns of youth marijuana use compromise their futures? . Addiction 114:6, pages 1049-1050.
Crossref
Jake RosenbergMallory J.E. LoflinYasmin L. HurdMarcel O. Bonn-Miller. (2019) Prescribing Health Care Providers' Attitudes, Experiences, and Practices Surrounding Cannabis Use in Patients with Anxiety Disorders and Post-Traumatic Stress Disorder. Cannabis and Cannabinoid Research 4:2, pages 124-130.
Crossref
Katherine Walukevich-Dienst, T. Dylanne Twitty & Julia D. Buckner. (2019) Sexual minority women and Cannabis use: The serial impact of PTSD symptom severity and coping motives. Addictive Behaviors 92, pages 1-5.
Crossref
Alejandra Mondino, Matías Cavelli, Joaquín González, Noelia Santana, Santiago Castro-Zaballa, Bùrix Mechoso, Nelson Bracesco, Santiago Fernandez, Carlos Garcia-Carnelli, María José Castro, Eleuterio Umpierrez, Eric Murillo-Rodriguez, Pablo Torterolo & Atilio Falconi. (2019) Acute effect of vaporized Cannabis on sleep and electrocortical activity. Pharmacology Biochemistry and Behavior 179, pages 113-123.
Crossref
Mohammad Abdi, Akbar Pourrahimi, Khalil Yousefi, Zahra Nouri Khaneghah, Soheila Rabie Siahkali & Hojjat Torkmandi. (2019) A Preventive Approach to the Risk of Substance Abuse in Medical Personnel with Migraine: A Case Report. Preventive Care In Nursing and Midwifery Journal 8:4, pages 23-26.
Crossref
Jung Yeon Lee, Wonkuk Kim & Judith S. Brook. (2019) Triple comorbid trajectories of alcohol, cigarette, and marijuana use from adolescence to adulthood predict insomnia in adulthood. Addictive Behaviors 90, pages 437-443.
Crossref
Darby J. E. Lowe, Julia D. Sasiadek, Alexandria S. Coles & Tony P. George. (2018) Cannabis and mental illness: a review. European Archives of Psychiatry and Clinical Neuroscience 269:1, pages 107-120.
Crossref
Michael Stillman, Michael Mallow, Tracy Ransom, Kristin Gustafson, Alison Bell & Daniel Graves. (2019) Attitudes toward and knowledge of medical cannabis among individuals with spinal cord injury. Spinal Cord Series and Cases 5:1.
Crossref
Claudia Salazar, Rachel Tomko, Saima Akbar, Lindsay Squeglia & Erin McClure. (2019) Medical Cannabis Use among Adults in the Southeastern United States. Cannabis 2:1, pages 53-65.
Crossref
Deepika Slawek, Senthil Raj Meenrajan, Marika Rose Alois, Paige Comstock Barker, Irene Mison Estores & Robert Cook. (2019) Medical Cannabis for the Primary Care Physician. Journal of Primary Care & Community Health 10, pages 215013271988483.
Crossref
Christina L. Vaughan & Alan C. Carver. 2019. Neuropalliative Care. Neuropalliative Care 239 255 .
Rachel L. Gunn, Kristina M. Jackson, Brian Borsari & Jane Metrik. (2018) Negative urgency partially accounts for the relationship between major depressive disorder and marijuana problems. Borderline Personality Disorder and Emotion Dysregulation 5:1.
Crossref
Amber L. Bahorik, Stacy A. Sterling, Cynthia I. Campbell, Constance Weisner, Danielle Ramo & Derek D. Satre. (2018) Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. Journal of Affective Disorders 241, pages 8-14.
Crossref
Nancy J. Kepple & Bridget Freisthler. (2018) Who’s Buying What and How Much? Correlates of Purchase Behaviors From Medical Marijuana Dispensaries in Los Angeles, California. The Journal of Primary Prevention 39:6, pages 571-589.
Crossref
David H. Morris, Alan K. Davis, Kirstin J. Lauritsen, C. Martin Rieth, Mark M. Silvestri, Jamie J. Winters & Stephen T. Chermack. (2018) Substance use consequences, mental health problems, and readiness to change among Veterans seeking substance use treatment. Journal of Substance Abuse Treatment 94, pages 113-121.
Crossref
Martin J. De Vita, Dezarie Moskal, Stephen A. Maisto & Emily B. Ansell. (2018) Association of Cannabinoid Administration With Experimental Pain in Healthy Adults. JAMA Psychiatry 75:11, pages 1118.
Crossref
Libat WeizmanLior DayanSilviu BrillHadas Nahman-AverbuchTalma HendlerGiris JacobHaggai Sharon. (2018) Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity. Neurology 91:14.
Crossref
Sharon Sznitman, Yifat Ben Baruch, Talya Greene & Marc Gelkopf. (2018) The association between physical pain and cannabis use in daily life: An experience sampling method. Drug and Alcohol Dependence 191, pages 294-299.
Crossref
Andrea M. Wycoff, Jane Metrik & Timothy J. Trull. (2018) Affect and cannabis use in daily life: a review and recommendations for future research. Drug and Alcohol Dependence 191, pages 223-233.
Crossref
Ziva D. Cooper, Gillinder Bedi, Divya Ramesh, Rebecca Balter, Sandra D. Comer & Margaret Haney. (2018) Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology 43:10, pages 2046-2055.
Crossref
Benjamin J. Morasco, Sarah E. Shull, Melissa H. Adams, Steven K. Dobscha & Travis I. Lovejoy. (2018) Development of an Algorithm to Identify Cannabis Urine Drug Test Results within a Multi-Site Electronic Health Record System. Journal of Medical Systems 42:9.
Crossref
Sheri L. Towe, Olivia E. Horton, Bianca Martin & Christina S. Meade. (2018) A Comparison of Motivations for Marijuana Use in HIV-Positive and HIV-Negative Adults. AIDS and Behavior 22:9, pages 2807-2814.
Crossref
Carrie Cuttler, Alexander Spradlin & Ryan J. McLaughlin. (2018) A naturalistic examination of the perceived effects of cannabis on negative affect. Journal of Affective Disorders 235, pages 198-205.
Crossref
Alexandra SiderisFahad KhanAlina BoltunovaGermaine CuffChristopher GhariboLisa V. Doan. (2018) New York Physicians' Perspectives and Knowledge of the State Medical Marijuana Program. Cannabis and Cannabinoid Research 3:1, pages 74-84.
Crossref
Nalini Vadivelu, Alice M. Kai, Gopal Kodumudi, Dan Haddad, Vijay Kodumudi, Niketh Kuruvilla, Alan David Kaye & Richard D. Urman. (2018) Recommendations for Substance Abuse and Pain Control in Patients with Chronic Pain. Current Pain and Headache Reports 22:4.
Crossref
Frédérique Bawin. (2018) Medisch gebruik van cannabis en zijn psychoactieve werking: een paradox?The medical use of cannabis and its psychoactive activity: a paradox?. Verslaving 14:1, pages 3-15.
Crossref
Stephen E. Lankenau, Janna Ataiants, Salini Mohanty, Sheree Schrager, Ellen Iverson & Carolyn F. Wong. (2018) Health conditions and motivations for marijuana use among young adult medical marijuana patients and non-patient marijuana users. Drug and Alcohol Review 37:2, pages 237-246.
Crossref
Stephen E. Lankenau, Avat Kioumarsi, Megan Reed, Miles McNeeley, Ellen Iverson & Carolyn F. Wong. (2018) Becoming a medical marijuana user. International Journal of Drug Policy 52, pages 62-70.
Crossref
Marian Wilson, Hannah Y. Gogulski, Carrie Cuttler, Teresa L. Bigand, Oladunni Oluwoye, Celestina Barbosa-Leiker & MaryLee A. Roberts. (2018) Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder. Addictive Behaviors 77, pages 225-231.
Crossref
Staci A. Gruber, Kelly A. Sagar, Mary K. Dahlgren, Atilla Gonenc, Rosemary T. Smith, Ashley M. Lambros, Korine B. Cabrera & Scott E. Lukas. (2018) The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment. Frontiers in Pharmacology 8.
Crossref
Deborah S Hasin. (2017) US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology 43:1, pages 195-212.
Crossref
Ziva D Cooper & Rebecca M Craft. (2017) Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. Neuropsychopharmacology 43:1, pages 34-51.
Crossref
Amber L. Bahorik, Cynthia I. Campbell, Stacy A. Sterling, Amy Leibowitz, Adam Travis, Constance M. Weisner & Derek D. Satre. (2018) Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Research 259, pages 316-322.
Crossref
Shannon M. Nugent, Bobbi Jo Yarborough, Ning X. Smith, Steven K. Dobscha, Richard A. Deyo, Carla A. Green & Benjamin J. Morasco. (2018) Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy. General Hospital Psychiatry 50, pages 104-110.
Crossref
Kipling M. Bohnert, Erin E. Bonar, J. Todd Arnedt, Deirdre A. Conroy, Maureen A. Walton & Mark A. Ilgen. (2018) Utility of the comprehensive marijuana motives questionnaire among medical cannabis patients. Addictive Behaviors 76, pages 139-144.
Crossref
James A. Cranford, J. Todd Arnedt, Deirdre A. Conroy, Kipling M. Bohnert, Carrie Bourque, Frederic C. Blow & Mark Ilgen. (2017) Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain. Drug and Alcohol Dependence 180, pages 227-233.
Crossref
Namkee G. Choi, Diana M. DiNitto & Carl Nathan Marti. (2017) Nonmedical versus medical marijuana use among three age groups of adults: Associations with mental and physical health status. The American Journal on Addictions 26:7, pages 697-706.
Crossref
Yih-Ing Hser, Larissa J. Mooney, David Huang, Yuhui Zhu, Rachel L. Tomko, Erin McClure, Chih-Ping Chou & Kevin M. Gray. (2017) Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment 81, pages 53-58.
Crossref
Lesia M. Ruglass, Alina Shevorykin, Christina Brezing, Mei-Chen Hu & Denise A. Hien. (2017) Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. Journal of Substance Abuse Treatment 80, pages 45-51.
Crossref
Erin E. Bonar, Jason E. Goldstick, R. Lorraine Collins, James A. Cranford, Rebecca M. Cunningham, Stephen T. Chermack, Frederic C. Blow & Maureen A. Walton. (2017) Daily associations between cannabis motives and consumption in emerging adults. Drug and Alcohol Dependence 178, pages 136-142.
Crossref
Nancy A. Haug, Claudia B. Padula, James E. Sottile, Ryan Vandrey, Adrienne J. Heinz & Marcel O. Bonn-Miller. (2017) Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addictive Behaviors 72, pages 14-20.
Crossref
Philippe Lucas & Zach Walsh. (2017) Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy 42, pages 30-35.
Crossref
Kimberly A. Babson, James Sottile & Danielle Morabito. (2017) Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Current Psychiatry Reports 19:4.
Crossref
Rebecca J. Bluett, Rita Báldi, Andre Haymer, Andrew D. Gaulden, Nolan D. Hartley, Walker P. Parrish, Jordan Baechle, David J. Marcus, Ramzi Mardam-Bey, Brian C. Shonesy, Md. Jashim Uddin, Lawrence J. Marnett, Ken Mackie, Roger J. Colbran, Danny G. Winder & Sachin Patel. (2017) Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Nature Communications 8:1.
Crossref
Zach Walsh, Raul Gonzalez, Kim Crosby, Michelle S. Thiessen, Chris Carroll & Marcel O. Bonn-Miller. (2017) Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review 51, pages 15-29.
Crossref
Sybil Goulet-Stock, Sergio Rueda, Afshin Vafaei, Anca Ialomiteanu, Jakob Manthey, Jürgen Rehm & Benedikt Fischer. (2017) Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics. European Addiction Research 23:3, pages 129-135.
Crossref
Bryson C. LochteAlexander BeletskyNebiyou K. SamuelIgor Grant. (2017) The Use of Cannabis for Headache Disorders. Cannabis and Cannabinoid Research 2:1, pages 61-71.
Crossref
Stephen E. Lankenau, Ekaterina V. Fedorova, Megan Reed, Sheree M. Schrager, Ellen Iverson & Carolyn F. Wong. (2017) Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. Drug and Alcohol Dependence 170, pages 181-188.
Crossref
Neomi Vin-Raviv, Tomi Akinyemiju, Qingrui Meng, Swati Sakhuja & Reid Hayward. (2017) Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database. Cancer Medicine 6:1, pages 320-329.
Crossref
Varuni Asanka de Silva, Nicholas Jayasekera & Raveen Hanwella. (2016) Cannabis use among Navy personnel in Sri Lanka: a cross sectional study. BMC Research Notes 9:1.
Crossref
Simon Haroutounian, Yael Ratz, Yehuda Ginosar, Karina Furmanov, Fayez Saifi, Ronit Meidan & Elyad Davidson. (2016) The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain. The Clinical Journal of Pain 32:12, pages 1036-1043.
Crossref
Nancy A. HaugDustin KieschnickJames E. SottileKimberly A. BabsonRyan VandreyMarcel O. Bonn-Miller. (2016) Training and Practices of Cannabis Dispensary Staff. Cannabis and Cannabinoid Research 1:1, pages 244-251.
Crossref
Silvia S. Martins, Christine M. Mauro, Julian Santaella-Tenorio, June H. Kim, Magdalena Cerda, Katherine M. Keyes, Deborah S. Hasin, Sandro Galea & Melanie Wall. (2016) State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug and Alcohol Dependence 169, pages 26-32.
Crossref
Alan K. Davis, Erin E. Bonar, Mark A. Ilgen, Maureen A. Walton, Brian E. Perron & Stephen T. Chermack. (2016) Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment. Addictive Behaviors 63, pages 132-136.
Crossref
Ziva D. Cooper & Margaret Haney. (2016) Sex-dependent effects of cannabis-induced analgesia. Drug and Alcohol Dependence 167, pages 112-120.
Crossref
Lewei A. Lin, Mark A. Ilgen, Mary Jannausch & Kipling M. Bohnert. (2016) Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample. Addictive Behaviors 61, pages 99-103.
Crossref
Nadia Chowdhury, Salpi Kevorkian, Christina M. Sheerin, Michael J. Zvolensky & Erin C. Berenz. (2015) Examination of the Association Among Personality Traits, Anxiety Sensitivity, and Cannabis Use Motives in a Community Sample. Journal of Psychopathology and Behavioral Assessment 38:3, pages 373-380.
Crossref
Arthur Robin WilliamsMark OlfsonJune H. KimSilvia S. MartinsHerbert D. Kleber. (2016) Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer ‘Medicalized’ Programs. Health Affairs 35:3, pages 480-488.
Crossref
Katherine A Belendiuk, Lisa L Baldini & Marcel O Bonn-Miller. (2015) Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addiction Science & Clinical Practice 10:1.
Crossref
Nehama Lewis, Doron Broitman & Sharon R. Sznitman. (2015) Medical Cannabis. Science Communication 37:6, pages 675-702.
Crossref
Katherine A. Belendiuk, Kimberly A. Babson, Ryan Vandrey & Marcel O. Bonn-Miller. (2015) Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addictive Behaviors 50, pages 178-181.
Crossref
Kimberly A Babson, Danielle E Ramo, Lisa Baldini, Ryan Vandrey & Marcel O Bonn-Miller. (2015) Mobile App-Delivered Cognitive Behavioral Therapy for Insomnia: Feasibility and Initial Efficacy Among Veterans With Cannabis Use Disorders. JMIR Research Protocols 4:3, pages e87.
Crossref
Eva Hoch, Udo Bonnet, Rainer Thomasius, Florian Ganzer, Ursula Havemann-Reinecke & Ulrich W. Preuss. (2015) Risks Associated With the Non-Medicinal Use of Cannabis. Deutsches Ärzteblatt international.
Crossref
Lisham Ashrafioun, Kipling M. Bohnert, Mary Jannausch & Mark A. Ilgen. (2015) Characteristics of substance use disorder treatment patients using medical cannabis for pain. Addictive Behaviors 42, pages 185-188.
Crossref
Kipling M. Bohnert, Brian E. Perron, Lisham Ashrafioun, Felicia Kleinberg, Mary Jannausch & Mark A. Ilgen. (2014) Positive posttraumatic stress disorder screens among first-time medical cannabis patients: Prevalence and association with other substance use. Addictive Behaviors 39:10, pages 1414-1417.
Crossref
Kimberly A. Babson & Marcel O. Bonn-Miller. (2014) Sleep Disturbances: Implications for Cannabis Use, Cannabis Use Cessation, and Cannabis Use Treatment. Current Addiction Reports 1:2, pages 109-114.
Crossref
Matthew Tyler Boden, Kimberly A. Babson, Anka A. Vujanovic, Nicole A. Short & Marcel O. Bonn-Miller. (2013) Posttraumatic Stress Disorder and Cannabis Use Characteristics among Military Veterans with Cannabis Dependence. The American Journal on Addictions 22:3, pages 277-284.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.